Cancers Clinical Trial - Cancer Survivor Registry: The Breast Cancer

Status Completed

Clinical Trial Summary

Cancer Survivor Registry: The Breast Cancer M.A. P. (Mind Affects the Physical M.A.P.) Project to identify and help us understand the emotional and social needs of breast cancer survivors.

Clinical Trial Description

The Cancer Survivor Registry: The Breast Cancer M.A.P. (Mind Affects the Physical) Project was the first registry of its kind to look at the emotional and social needs of individuals diagnosed with breast cancer and track how their needs changed throughout their cancer journey. Data will raise awareness and help develop programs to address the needs of breast cancer survivors. Findings from the Registry are disseminated online at www.CancerSupportCommunity.org/RegistryIndexReport2017 ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01295658
Study type	Observational
Source	Cancer Support Community, Research and Training Institute, Philadelphia
Contact
Status	Completed
Phase
Start date	May 2010
Completion date	March 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01127711` - Cohort of Swedish Men	N/A
Recruiting	`NCT05299710` - Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)
Completed	`NCT01127698` - Swedish Mammography Cohort	N/A
Completed	`NCT02734303` - Study to Estimate Radiation Doses and Cancer Risks From Radioactive Fallout From the Trinity Nuclear Test
Completed	`NCT01646437` - The International Polycap Study 3 (TIPS-3)	Phase 3
Completed	`NCT01441674` - Animal Assisted Therapy in a Pediatric Setting	Phase 1/Phase 2
Completed	`NCT04198896` - The Sakakibara Health Integrative Profile of Atherosclerotic-Carcinogenesis Hypothesis (SHIP-AC)
Completed	`NCT01185470` - The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain	Phase 2/Phase 3
Completed	`NCT00484016` - Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected NCSLC	N/A
Completed	`NCT03378895` - CEPPPIA Pilot. Experimental Center of Participative and Individualized Predictive Prevention in Auvergne	N/A
Recruiting	`NCT06046066` - A Phase 1 Study of NM6603 in Advanced Solid Tumors	Phase 1
Not yet recruiting	`NCT06416267` - Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL)